GLP-1 Beef Demand Meets a 75-Year-Low U.S. Cow Herd

Some patients taking GLP-1 drugs for obesity remain willing to pay $8 per pound for ground beef and visit high-priced steakhouses, according to Farm Credit Services of America. Its senior vice president of corporate credit, Fallon Savage, supplied that market observation.

What is sustaining beef demand?

Consumers show no signs of cutting beef purchases despite inflation. That matters because higher prices normally push shoppers toward less-expensive pork and chicken, but shoppers are not making that switch now.

Savage said: “We still continue to see beef as a primary protein choice.” Her observation indicates resilient demand, although no sales data or reporting window accompanies it.

She attributes part of that resilience to patients taking GLP-1 drugs. “Because they are consuming less calories, these consumers are willing to spend more on protein,” Savage said.

The $8 figure describes what these consumers will pay for ground beef, not an industrywide benchmark. The source supplies no survey methodology, and some patients also continue to patronize high-dollar steakhouses.

Could GLP-1 drugs become agriculture’s next ethanol?

Savage compares the potential combination of GLP-1 drugs and beef with the effect corn and ethanol had on agriculture roughly 20 years ago. Her view is that GLP-1 medications could create another broad change in farm demand, but that outcome remains a forecast, not a completed shift.

That logic also explains why beef demand has not followed the usual path during inflation. Consumers are not shifting from beef to pork or chicken, and some are concentrating more of their food budgets on protein. The source does not quantify how many patients drive the pattern or whether demand differs by market.

What does a 75-year-low cow herd mean for prices?

Declining cow numbers could support cattle prices. Drought has helped drive the U.S. cow herd to its lowest level in 75 years, while severe drought in western Nebraska, Colorado, parts of South Dakota and Kansas has caused large-scale liquidation of cattle.

Those conditions tighten cattle supply, but the source offers no price target or cattle basis (the difference between local cash and futures prices). Producers therefore cannot treat stronger prices as a guaranteed margin gain.

Should producers retain or sell heifers?

Grass availability is Savage’s first question when assessing herd rebuilding. Producers who must put up hay or place cattle in a lot early face tighter, thinner margins because forage (pasture and hay feed) and early feeding costs arrive before the expanded herd can generate returns.

Selling heifer calves (young female cattle) provides quick cash that producers may need for debt payments or other monetary obligations. The trade-off is immediate liquidity against the future breeding and production capacity of those animals.

Ample grass favors retaining heifers and expanding. Central Iowa offers a favorable example, with lush fall pastures following the heaviest September precipitation in more than 100 years. Savage considers that setting supportive of further herd growth.

That is a pasture-condition report, not evidence that every operation in central Iowa will expand. A lush season can ease forage constraints, while operations without grass remain more dependent on hay and early lot placement, the conditions Savage says compress margins.

Can crop farmers add cattle without weakening the balance sheet?

Some crop farmers considering beef cows can treat cattle as diversification (adding another farm enterprise), Savage said. Before buying, they need to examine the farm balance sheet (assets, liabilities and cash position) and confirm that it can withstand a couple of years while the cow herd develops.

No new subsidy or policy change underpins the expansion case in Savage’s analysis, and the source provides no repayment schedule or operating-cost budget. Its financial test is whether the operation can finance two years of herd buildup without weakening its ability to meet existing obligations.

The recommendation is not a blanket endorsement of cattle expansion. It applies first to operations with reliable grass access; crop farmers must separately determine whether a new herd fits their financial plan.

The recommendations form part of the ongoing “Smart Moves for 2027” series, which offers steps to guide farmers’ decisions in the coming year. For 2027, the decisive variables are grass access and balance-sheet capacity, even if GLP-1-linked protein demand and a smaller cow herd continue to support cattle prices.